🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We tested the feasibility and immunogenicity of a personalized neoantigen vaccine + PD-L1 blockade in #bladdercancer including the adjuvant setting. nature.com/articles/s4301… Jon Anker, MD, PhD Bhardwaj Lab UroToday.com Uromigos The Tisch Cancer Institute Dr. Bishoy M. Faltas Nature Cancer Bladder Cancer Advocacy Network

Ab#4506 ASCO #ASCO25 by Toni Choueiri, MD👉bit.ly/3H57gZC👉Results from Ph 1 ARC-20 study #kidneycancer👉Casdatifan + Cabo has promising activity (manageable AEs) in pts w/ previously treated RCC👇#AlexandraDrakaki OncoAlert UroToday.com @KidneyCAN Kidney Cancer

🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. SRS Standard of Care for 5-20 brain mets 🚨🚨🚨

From surveillance to surgery, Eric Singer, MD, MS, explains how Ohio State kidney cancer experts provide patients with the latest techniques and treatments to save and improve lives.

Check our presentations, meet the experts at the booth and more ! OSUCCC The James at #ASCO25! ⁦The James⁩ ⁦Ohio State Medical Oncology⁩ See you all in Chicago!! cancer.osu.edu/for-cancer-res…

Division Director ⁦Christian Rolfo⁩ welcomes you all to join ⁦The James⁩ and ⁦Ohio State Medical Oncology⁩ at #ASCO25 and learn about ways to #BeABuckeye 🌰 youtube.com/watch?v=ufgygH…

The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉

🚨Update Randomized Trial: Significantly Better KPS & Cognitive Function with SRS compared to HA-WBRT for 5-20 brain mets 🚨🚨🚨

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

Proud to be part of this pivotal trial and to have learned so much from Dr. Srinivasan and our patients. ⁦National Cancer Institute⁩⁩ ⁦The James⁩ ⁦Ohio State Wexner Medical Center Urology Dept.⁩ ⁦Kimryn Rathmell⁩ ⁦Kidney Cancer⁩ ⁦KidneyCAN⁩ ⁦IKCC Kidney Cancer⁩ ⁦⁦Kidney Cancer Canada⁩

Starting the day with #ASCO25 Review at Ohio State Medical Oncology with an stellar lineup of speakers with our chairs Asrar AlAhmadi, MD, MAS-CR - أسرار الأحمدي & Ashish Manne a great opportunity for an update and networking with our colleagues from Ohio! Logan Roof, MD, MS Lingbin Meng Elshad Hasanov, MD, PhD The James

Great discussions and questions at the panel debate on the #ASCO25 Review at Ohio State Medical Oncology Lingbin Meng Asrar AlAhmadi, MD, MAS-CR - أسرار الأحمدي Logan Roof, MD, MS Elshad Hasanov, MD, PhD David Carbone MD Ashish Manne The James

🤗 We're excited to have our friend Kimryn Rathmell The James join us for a conversation about leadership and career building during our Women in RCC Summer Webinar! 📆 August 14 🕰️ 7:00-8:00 pm ET 👉 Register: bit.ly/3Gf9wgV #kidneycancer #womeninscience

⁦Kimryn Rathmell⁩ delivering the keynote address at #KCRS25. ⁦The Ohio State University Wexner Medical Center⁩ ⁦The James⁩ ⁦Ohio State Wexner Medical Center Urology Dept.⁩ ⁦KidneyCAN⁩

Inspiring Keynote speech from Kimryn Rathmell at KidneyCAN #KCRS25: “The bottom line is we need more people going into science, and open doors to engage the public in partnership.” The James Pelotonia Institute for Immuno-Oncology Ohio State Medical Oncology Pelotonia Eric A. Singer, MD, MA, MS, FACS, FASCO

Bright future ahead for kidney cancer with tumor neoantigen vaccine, inducing ferroptosis, KIM-1 biomarker, dual targeting CAIX/CD70 CAR-T cell. A great session at KidneyCAN #KCRS25 by Eric Jonasch #CherylWalker David Braun #MeiKoh #WayneMarasco Wenxin (Vincent) Xu

Lindsey Byrne discussing genetic testing for RCC at #KCRS25. ⁦The Ohio State University Wexner Medical Center⁩ ⁦The James⁩ ⁦Ohio State Wexner Medical Center Urology Dept.⁩

Big sis Nazli Dizman presented an innovative trial evaluating the first bispecific PDL1/VEGF targeting agent Always one step ahead! Looking forward to seeing results! OncoAlert

Congratulation to Dr. Marston Linehan on receiving the inaugural Kidney Cancer Hall of Fame award from KidneyCAN at #KCRS25. A mentor to many of us and an inspiration to all in the kidney cancer community.